Skip to content

Legal status · Australia

Is HEC88473 legal in Australia?

Written by Reviewed Sep 2026

Not approvedMetabolicHuman studies cited: 1

Direct answer

No. HEC88473 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 1 human study is cited on its profile.

HEC88473 in Australia at a glance

ClassificationInvestigational, not registered
TGA approval statusNot approved by TGA; investigational
Human studies cited1 of 1 citations on the profile
ReviewedSep 2026

Classification and note come from the HEC88473 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.

What this means

  • 01

    HEC88473 is being studied in registered clinical trials but has not received TGA marketing approval in Australia.

  • 02

    Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.

  • 03

    Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.

What HEC88473 is

The only GLP-1 pairing on this site that is not with another incretin. Combining GLP-1 with FGF21 targets appetite and liver metabolism through genuinely separate pathways.

Almost every dual agonist documented here pairs GLP-1 with GIP, glucagon or amylin, all of which are gut or pancreatic hormones acting on related receptors. This one pairs it with FGF21, which is a different kind of signal entirely.

Mechanism: A single molecule with agonist activity at both the GLP-1 receptor and the FGF21 receptor complex. GLP-1 receptor agonism reduces food intake and improves glycaemic control conventionally.

Regulatory history: Investigational. First-in-human only. Not approved anywhere.

How TGA treats this kind of product

Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.

The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for HEC88473 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.

HEC88473 in other countries

Frequently asked questions

Is HEC88473 legal in Australia?

No. HEC88473 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 1 human study is cited on its profile.

Can I buy HEC88473 in Australia?

No approved product exists to buy. In Australia HEC88473 is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.

Is HEC88473 TGA approved?

No. In Australia HEC88473 is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational. First-in-human only. Not approved anywhere.. On the evidence, 1 human study is cited on its profile.

Related compounds in Australia

Full research profile

Mechanism, cited studies, FDA status and the full legal summary for HEC88473 live on its compound profile.

HEC88473 profile

This page is general information about the regulatory status of HEC88473 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.